MED 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

03
价格 $11.73
市值 (MRQ) $131M
P/E (TTM) -5.1
EPS (TTM) $-2.32
收入 (TTM) $317M
股息收益率 0.15%
ROE (TTM) -12.4%
52周区间 $9–$14

MED 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

04
区间
条形图

柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。

关于 MEDIFAST INC Common Stock 公司概况(来自维基百科)

05 · wikidata

Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Subsidiaries

The company owns five subsidiaries:

Jason Pharmaceuticals, Inc.

Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)

Jason Enterprises, Inc.

Jason Properties, LLC

Seven Crondall, LLC

History

William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.

The company is publicly traded on the New York Stock Exchange (symbol: MED).

On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.

In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”

In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.

Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.

In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.

In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.

In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.

False advertising settlement

In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

行业板块Consumer products 行业Consumer products 员工380 国家US

10年表现 收入、净利润、利润率和每股收益趋势

06
收入$386M
2016-12-31 → 2025-12-31
EPS$-1.70
2016-12-31 → 2025-12-31
自由现金流$1M
2016-12-31 → 2025-12-31
净利率-8.1%
2016-12-31 → 2025-12-31
估值与比率 07–12

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标 5年趋势 MED 5年均值 同行中位数 结论
P/E (TTM) -5.15年均值 ≈23.6 ≈23.6 · ·
P/S (TTM) 0.45年均值 ≈0.7 ≈0.7 0.8 低估
市净率 (MRQ) 0.75年均值 ≈5.0 ≈5.0 2.2 低估
股价/自由现金流 (TTM) 32.75年均值 ≈31.6 ≈31.6 · ·
市现率 (TTM) 14.95年均值 ≈12.4 ≈12.4 13.9 价格较高
Price / Tangible Book (市净率(有形资产)) 0.65年均值 ≈5.0 ≈5.0 · ·

同行中位数按每项指标的标准化基础计算,可能与本股票显示的TTM/MRQ基础不完全匹配。

价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判

股息 收益率、派息率、股息历史、5年CAGR

13
股息收益率0.15%
派息率-1.0%
年度化派息≈$6.60每季度支付
除息日金额货币收益率
九月 18, 2023$1.65USD≈8.2%
六月 26, 2023$1.65USD≈7.3%
三月 27, 2023$1.65USD≈6.6%
十二月 19, 2022$1.64USD≈5.7%
九月 19, 2022$1.64USD≈5.4%
六月 27, 2022$1.64USD≈3.2%
三月 28, 2022$1.64USD≈3.5%
十二月 20, 2021$1.42USD≈2.6%
九月 20, 2021$1.42USD≈2.5%
六月 21, 2021$1.42USD≈1.9%
三月 29, 2021$1.42USD≈2.3%
十二月 21, 2020$1.13USD≈2.3%
九月 21, 2020$1.13USD≈3.1%
六月 29, 2020$1.13USD≈3.0%
三月 30, 2020$1.13USD≈5.9%
十二月 26, 2019$1.13USD≈3.1%
九月 26, 2019$0.75USD≈3.0%
六月 27, 2019$0.75USD≈2.5%
三月 28, 2019$0.75USD≈1.9%
十二月 20, 2018$0.75USD≈1.8%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

14
平均惊喜 54.6%
下次报告 十一月 02, 2026
期间报告EPS ActualEPS 预期惊喜
2026年6月30日 八月 10, 2026 $-0.28 $-0.66 57.3%
2026年3月31日 $-0.19 $-0.53 63.8%
2025年12月31日 $-1.65 $-0.83 -99.2%
2025年9月30日 $-0.21 $-0.39 46.7%
2025年6月30日 $0.22 $-0.22 199.0%
2025年3月31日 $-0.11 $-0.27 59.7%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

15
损益表 15
指标 趋势 202520242023202220212020201920182017201620152014
Revenue $386M$602M$1.07B$1.60B$1.53B$935M$714M$501M$302M$275M$273M$285M
Cost of Revenue $111M$158M$296M$458M$398M$237M$177M$121M$74M$69M$71M$76M
Gross Profit $275M$445M$776M$1.14B$1.13B$698M$537M$380M$228M$206M$201M$209M
R&D Expense $4M$5M$5M$4M$4M$3M$3M$2M$2M$2M$2M$1M
SG&A Expense $289M$442M$649M$956M$911M$564M$446M$311M$188M$179M$173M$179M
Operating Income $-14M$3M$126M$185M$216M$134M$91M$69M$40M$27M$29M$30M
Other Non-op $3M$-4M$-95.0K$-747.0K$119.0K$-140.0K$29.0K$179.0K$136.0K$-20.0K$326.0K$731.0K
Pretax Income $-6M$4M$129M$184M$216M$134M$92M$71M$40M$27M$30M$32M
Income Tax $13M$2M$29M$40M$52M$31M$14M$15M$13M$9M$10M$11M
Net Income $-19M$2M$99M$144M$164M$103M$78M$56M$28M$18M$20M$13M
EPS (Basic) $-1.70$0.19$9.13$12.82$14.01$8.74$6.62$4.67$2.32$1.51$1.68$1.04
EPS (Diluted) $-1.70$0.19$9.10$12.73$13.89$8.68$6.43$4.62$2.29$1.49$1.66$1.03
Shares (Basic) 10,981,00010,930,00010,884,00011,195,00011,705,00011,771,00011,771,00011,947,00011,924,00011,842,00011,959,00012,670,000
Shares (Diluted) 10,981,00010,963,00010,921,00011,276,00011,813,00011,850,00012,117,00012,079,00012,088,00011,947,00012,071,00012,778,000
EBITDA $29.0K$16M$140M$196M$223M$141M$96M$73M$44M$32M$36M·
资产负债表 24
指标 趋势 202520242023202220212020201920182017201620152014
Cash & Equivalents $89M$91M$94M$88M$104M$164M$77M$81M$75M$52M$42M$24M
Short-term Investments $78M$71M$56M$0$5M$11M$16M$20M$24M$24M$25M$28M
Receivables ·····$584.0K$1M$1M$576.0K$1M$2M$2M
Inventory $20M$42M$55M$119M$180M$53M$49M$39M$19M$18M$13M$16M
Prepaid Expense $9M$10M$11M$16M$16M$6M$6M$5M$4M$4M$3M$3M
Current Assets $202M$214M$224M$223M$307M$234M$154M$146M$125M$101M$87M$82M
PP&E (Net) $31M$38M$51M$57M$56M$28M$26M$20M$19M$20M$29M$33M
PP&E (Gross) $99M$96M$99M$97M$89M$55M$49M$54M$52M$56M$75M$74M
Accum. Depreciation $68M$58M$47M$40M$33M$27M$23M$35M$33M$36M$46M$40M
Other Non-current Assets $8M$10M$15M$12M$6M$3M$353.0K$1M$2M$162.0K$205.0K$497.0K
Total Assets $248M$284M$310M$316M$398M$276M$195M$169M$146M$121M$116M$116M
Accounts Payable $38M$56M$86M$135M$163M$108M$76M$60M$37M$24M$23M$22M
Current Liabilities $43M$64M$92M$141M$170M$111M$79M$60M$37M$24M$24M$27M
Capital Leases $6M$10M$16M$20M$26M$7M$10M···$0$242.0K
Deferred Tax ········$208.0K$779.0K$4M$5M
Total Liabilities $49M$74M$108M$161M$196M$119M$90M$60M$37M$25M$28M$35M
Common Stock $11.0K$11.0K$11.0K$11.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K$12.0K
Paid-in Capital $40M$33M$27M$22M$12M$8M·$9M$5M$3M$0$1M
Retained Earnings $158M$177M$175M$140M$190M$154M$169M$131M$104M$93M$89M$79M
Treasury Stock ··$0$6M$0$5M$64M$31M···$0
AOCI $234.0K$180.0K$248.0K$24.0K$111.0K$41.0K$25.0K$-173.0K$-160.0K$-165.0K$-62.0K$435.0K
Stockholders' Equity $199M$210M$201M$155M$202M$157M$105M$109M$107M$96M$89M$80M
Liabilities + Equity $248M$284M$310M$316M$398M$276M$195M$169M$146M$121M$116M$116M
Shares Outstanding 10,991,00010,938,00010,896,00010,873,00011,593,00011,772,00011,764,00011,868,00011,971,00011,871,00011,797,00012,075,764
现金流 16
指标 趋势 202520242023202220212020201920182017201620152014
D&A $14M$13M$13M$11M$7M$4M$5M$4M$4M$5M$7M$8M
Stock-based Comp $8M$7M$8M$11M$10M$7M$5M$3M$4M$3M$3M$4M
Deferred Tax $11M$-7M$1M$-924.0K$-4M$601.0K$2M$-3M$-623.0K$-3M$-106.0K$286.0K
Restructuring ·········$1M··
Other Non-cash $-8M$10M$26M$30M$-82M$28M$-4M$155.0K$8M$2M$-737.0K·
Operating Cash Flow $7M$24M$148M$195M$95M$145M$84M$61M$43M$25M$29M$26M
CapEx $6M$7M$6M$17M$34M$6M$10M$5M$3M$3M$3M$7M
Investing Cash Flow $-8M$-27M$-61M$-11M$-29M$-1M$-6M$-1M$-3M$-2M$-189.0K$-3M
Net Debt Issued ·········$-219.0K$-255.0K·
Stock Repurchased $0$0$4M$126M$56M$5M$33M$30M··$11M$34M
Net Stock Activity $0$0$-4M$-126M$-56M$-5M$-33M$-30M··$-11M·
Dividends Paid $195.0K$715.0K$73M$72M$64M$53M$35M$23M$15M$12M··
Financing Cash Flow $-564.0K$-2M$-80M$-200M$-125M$-57M$-82M$-53M$-17M$-13M$-12M$-35M
Net Change in Cash $-2M$-4M$7M$-16M$-60M$87M$-4M$6M$23M$10M$18M$-12M
Taxes Paid $10M$-2M$34M$37M········
Free Cash Flow $1M$17M$141M$178M$60M$139M$74M$56M$40M$22M$27M·
盈利能力 8
指标 趋势 202520242023202220212020201920182017201620152014
Gross Margin 71.3%73.8%72.4%71.3%73.9%74.7%75.2%75.8%75.5%74.9%73.8%·
Operating Margin -3.7%0.48%11.8%11.6%14.2%14.3%12.8%13.8%13.1%9.8%10.5%·
Net Margin -4.8%0.35%9.3%9.0%10.8%11.0%10.9%11.1%9.2%6.5%7.3%·
Pretax Margin -1.5%0.63%12.0%11.5%14.2%14.4%12.9%14.1%13.4%9.9%10.9%·
EBITDA Margin 0.01%2.6%13.0%12.2%14.6%15.1%13.4%14.7%14.5%11.8%13.1%·
ROA -7.0%0.70%31.8%40.2%48.6%43.7%42.8%35.4%20.8%15.0%17.2%·
ROE -9.0%1.0%50.4%94.0%82.3%69.2%72.1%50.5%27.1%19.3%23.7%·
ROIC -23.7%0.76%48.4%93.0%81.1%65.4%73.3%50.1%25.1%18.4%21.3%·
流动性与偿付能力 2
指标 趋势 202520242023202220212020201920182017201620152014
Current Ratio 4.73.32.41.61.82.11.92.43.44.13.7·
Quick Ratio 3.92.51.00.60.61.61.21.72.73.22.9·
效率 3
指标 趋势 202520242023202220212020201920182017201620152014
Asset Turnover 1.42.03.44.54.54.03.93.22.32.32.3·
Inventory Turnover 3.53.33.43.13.44.64.04.13.94.44.9·
Receivables Turnover ·····925.1583.1467.4307.2181.8166.2·
每股 6
指标 趋势 202520242023202220212020201920182017201620152014
Book Value / Share $18.10$19.21$18.49$14.26$17.47$13.36$8.91$9.19$9.07$8.09$7.51·
Revenue / Share $35.13$54.95$98.16$141.77$129.19$78.89$58.90$41.48$24.95$22.98$22.60·
Cash Flow / Share $0.62$2.23$13.52$17.26$8.00$12.25$6.95$5.03$3.58$2.12$2.44·
Cash / Share $8.13$8.31$8.67$8.06$8.99$13.91$6.54$6.86$6.27$4.42$3.56·
Dividend / Share $0.00$0.00$4.95$6.56$5.68$4.52$3.38$2.19$1.44$1.07$0.25$0.00
EPS (TTM) $-1.70$0.19$9.10$12.73$13.89$8.68$6.43$4.62$2.29$1.49$1.66$1.03
增长率 8
指标 趋势 202520242023202220212020201920182017201620152014
Revenue YoY -36.0%-43.8%-32.9%4.8%63.2%·······
Revenue CAGR 3Y -37.7%-26.6%4.7%·········
Revenue CAGR 5Y -16.2%···········
EPS YoY ·-97.9%-28.5%-8.3%60.0%·······
EPS CAGR 3Y ·-76.1%1.6%·········
Net Income YoY ·-97.9%-30.8%-12.5%59.5%·······
Net Income CAGR 3Y ·-76.6%-1.1%·········
Dividends Paid CAGR 5Y -67.4%···········
估值 (TTM) 13
指标 趋势 202520242023202220212020201920182017201620152014
Revenue TTM $386M$602M$1.07B$1.60B$1.53B$935M$714M$501M$302M$275M$273M$285M
Net Income TTM $-19M$2M$99M$144M$164M$103M$78M$56M$28M$18M$20M$13M
Market Cap $117M$193M$732M$1.25B$2.43B$2.31B$1.29B$1.48B$836M$494M$358M·
P/E -6.392.77.49.115.122.617.027.130.527.918.332.6
P/S 0.30.30.70.81.62.51.83.02.81.81.3·
P/B 0.60.93.68.112.014.712.313.67.75.14.0·
P / Tangible Book 0.60.93.68.112.014.7······
P / Cash Flow 17.17.95.06.425.715.915.324.419.319.512.2·
P / FCF 94.011.35.27.140.216.617.426.620.922.013.5·
Dividend Yield 0.17%0.37%10.0%5.7%2.6%2.3%2.8%1.6%1.8%2.4%··
Earnings Yield -15.9%1.1%13.5%11.0%6.6%4.4%5.9%3.7%3.3%3.6%5.5%3.1%
Payout Ratio -1.0%34.2%73.5%49.9%38.9%51.7%45.4%41.5%55.5%66.7%··
Annual Payout $195.0K$715.0K$73M$72M$64M$53M$35M$23M$15M$12M··

最近期在左侧 · 空值显示为 ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

16
指标 2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $386M $602M $1.07B $1.60B $1.53B
毛利率 % 71.3% 73.8% 72.4% 71.3% 73.9%
营业利润率 % -3.7% 0.48% 11.8% 11.6% 14.2%
净收入 $-19M $2M $99M $144M $164M
稀释后每股收益 (EPS) $-1.70 $0.19 $9.10 $12.73 $13.89

机构持有人 (13F) 123 家申报者 · $106.7M 总计 · 截至 2026年9月30日

17

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

持有人 123
持有价值 $106.7M
新仓位 26
已退出持仓 24
机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
26 (-5 与上一季度对比) 24 (+7 与上一季度对比) 47 (+12 与上一季度对比) 29 (-4 与上一季度对比) -931K

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
RENAISSANCE TECHNOLOGIES LLC $8261052 778610 7.74% 股份
VANGUARD GROUP INC $7598810 711499 7.12% 股份
Steamboat Capital Partners, LLC $7498076 706699 7.03% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $5758047 542700 5.40% 买入期权
TWO SIGMA INVESTMENTS, LP $5107452 481381 4.79% 股份
VANGUARD CAPITAL MANAGEMENT LLC $4738575 446614 4.44% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $4212128 396996 3.95% 股份
BlackRock, Inc. $3920427 369503 3.68% 股份
DIMENSIONAL FUND ADVISORS LP $3855669 363394 3.61% 股份
AMERICAN CENTURY COMPANIES INC $3383646 318911 3.17% 股份
MORGAN STANLEY $3103524 292508 2.91% 股份
GOLDMAN SACHS GROUP INC $2579132 243085 2.42% 股份
MARSHALL WACE, LLP $2563897 241649 2.40% 股份
AQR CAPITAL MANAGEMENT LLC $2508564 236434 2.35% 股份
CITADEL ADVISORS LLC $2476374 233400 2.32% 买入期权
Peapod Lane Capital LLC $2361531 222576 2.21% 股份
Lido Advisors, LLC $2337779 220337 2.19% 股份
Trexquant Investment LP $2256577 212684 2.12% 股份
JANE STREET GROUP, LLC $1749388 164881 1.64% 股份
COMMONS CAPITAL, LLC $1590609 149916 1.49% 股份
Quinn Opportunity Partners LLC $1348658 127112 1.26% 股份
GEODE CAPITAL MANAGEMENT, LLC $1285312 121071 1.20% 股份
BRIDGEWAY CAPITAL MANAGEMENT, LLC $1242198 117078 1.16% 股份
RBF Capital, LLC $1156490 109000 1.08% 股份
Walleye Trading LLC $1145880 108000 1.07% 买入期权
TWO SIGMA ADVISERS, LP $1098972 102900 1.03% 股份
JPMORGAN CHASE & CO $989878 92512 0.93% 股份
D. E. Shaw & Co., Inc. $979780 92345 0.92% 股份
BANK OF AMERICA CORP /DE/ $924323 87118 0.87% 股份
Quantinno Capital Management LP $880598 82997 0.83% 股份
Divisadero Street Capital Management, LP $847092 79839 0.79% 股份
Virtus Family Office LLC $838827 79060 0.79% 股份
TUDOR INVESTMENT CORP ET AL $806689 76031 0.76% 股份
BNP PARIBAS FINANCIAL MARKETS $783846 73878 0.73% 股份
FEDERATED HERMES, INC. $738509 69605 0.69% 股份
Empowered Funds, LLC $701374 66105 0.66% 股份
CITADEL ADVISORS LLC $696016 65600 0.65% 卖出期权
VANGUARD FIDUCIARY TRUST CO $672006 63337 0.63% 股份
Atom Investors LP $659083 62119 0.62% 股份
CITADEL ADVISORS LLC $597873 56350 0.56% 股份
STATE STREET CORP $555105 52319 0.52% 股份
GREAT LAKES ADVISORS, LLC $547593 51611 0.51% 股份
UBS Group AG $532866 50223 0.50% 股份
Engineers Gate Manager LP $528686 49829 0.50% 股份
MILLENNIUM MANAGEMENT LLC $508283 47906 0.48% 股份
SummerHaven Investment Management, LLC $507529 47835 0.48% 股份
Centiva Capital, LP $471424 44432 0.44% 股份
Susquehanna Portfolio Strategies, LLC $443254 41777 0.42% 股份
Jump Financial, LLC $429705 40500 0.40% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $422278 39800 0.40% 卖出期权

显示全部 123 个机构持有人 →

激进投资者及 5%+ 股东 8 持仓

18

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
Parsa Kiai, Steamboat Capital Partners, LLC 2026年8月21日 7.10% 修订 · SEC
Steamboat Capital Partners, LLC, Parsa Kiai 2026年3月20日 6.00% 初始申报 董事会活动 SEC
Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest X, LP, Engaged Capital Co-Invest X-A, LP, Engaged Capital Opportunities Fund, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×5 申报 2020年7月15日 · 初始申报 · SEC
Engaged Capital Master Feeder II, LP, Engaged Capital Master Feeder I, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling 2016年6月3日 · 初始申报 · SEC
ModusLink Securities Corp., ModusLink Global Solutions, Inc. ×6 申报 2016年1月19日 · 初始申报 · SEC
Engaged Capital Master Feeder I, LP, Engaged Capital Master Feeder II, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×4 申报 2015年9月1日 · 初始申报 · SEC
未披露的报告人, 未披露的报告人 2002年12月12日 · 初始申报 · SEC
未披露的报告人, 未披露的报告人 2002年5月6日 · 初始申报 被动投资 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

公司内部人士 52 位内幕人士 · 20 位高管 · 28 位董事

19
内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Michael S Mcdevitt Chief Executive Officer 2011年1月5日 S 340012 0 0 $0
James P. Maloney Chief Financial Officer 2026年3月25日 A 73033 0 0 $0
Timothy G Robinson Chief Financial Officer 2020年2月20日 F 47214 0 0 $0
Connors Brendan Chief Financial Officer 2011年1月5日 S 91484 0 0 $0
Mehrnaz Mona Ameli President, OPTAVIA 2017年11月17日 F 10809 0 0 $0
Margaret Macdonald Sheetz President & COO 2016年4月1日 S 327346 0 0 $0
Jonathan Barrett Mackenzie VP, Finance & CAO 2026年3月25日 A 20838 0 0 $0
Stephen Kyle Johnson VP, Finance & CAO 2021年3月17日 A 665 0 0 $0
Joseph P Kelleman Vice President of Finance 2019年2月20日 A 2355 0 0 $0
Jason L Groves Executive VP & General Counsel 2015年2月17日 A 21697 0 0 $0
Jeanette M. Mills Executive Vice President 2014年8月18日 S 20116 0 0 $0
Guy Sheetz Executive Vice President 2014年2月5日 A 410430 0 0 $0
Dominick Vietri Executive Vice President 2014年2月5日 A 3804 0 0 $0
Brian Lloyd Executive Vice President 2014年2月5日 A 1865 0 0 $0
Donald Gould Executive Vice President 2014年2月5日 A 6804 0 0 $0
Brian Kagen Executive Vice President 2014年2月5日 A 3804 0 0 $0
Jeanne M Uphouse Executive Vice President 2014年2月5日 A 3804 0 0 $0
Brazdley T Macdonald Exec. Chairman of the Board 2011年1月5日 S 579521 0 0 $0
Leo Williams Executive Vice President 2010年11月29日 S 15000 0 0 $0
Robert J Hallock Corporate Vice President 2003年11月18日 P 1000 0 0 $0
Daniel R Chard 董事 2026年9月29日 S 130609 1 2 $-47575
Parsa Kiai 董事 2026年8月26日 P 20270 8 0 $1423577
Jeffrey Matthew Rose 董事 2026年5月26日 A 18419 0 0 $0
Elizabeth A. Geary 董事 2026年5月26日 A 31225 0 0 $0
Andrea B Thomas 董事 2026年5月26日 A 35697 0 0 $0
Ming Xian 董事 2026年5月26日 A · 0 0 $0
Scott Schlackman 董事 2026年5月26日 A 42229 2 0 $62950
Michael A. Hoer 董事 2025年6月25日 A 26139 0 0 $0
Jeffrey J Brown 董事 2025年6月25日 A 38578 0 0 $0
Kevin G Byrnes 董事 2021年11月11日 M 14922 0 0 $0
Michael C Macdonald 董事 2020年10月1日 S 266179 0 0 $0
Carl E Sassano 董事 2020年7月17日 G 18199 0 0 $0
Charles P Connolly 董事 2018年3月9日 M 41374 0 0 $0
Welling Glenn W. 董事 2017年12月1日 S 22380 0 0 $0
Jorgene K. Hartwig 董事 2017年3月13日 M 9808 0 0 $0
Barry B Bondroff 董事 2015年6月11日 S 14533 0 0 $0
John P Mcdaniel 董事 2015年6月4日 S 18289 0 0 $0
Jerry D Reece 董事 2015年2月17日 A 8792 0 0 $0
Harvey C Barnum JR 董事 2015年2月17日 A 8742 0 0 $0
Catherine T Maguire 董事 2015年2月17日 A 15074 0 0 $0
Donald F Reilly 董事 2015年2月17日 A 0 0 0 $0
George Lavin 董事 2013年7月31日 D 24785 0 0 $0
Joseph D Calderone 董事 2009年3月24日 A 21700 0 0 $0
Carthy Dennis Mc 董事 2009年3月24日 A 17075 0 0 $0
Michael J Mcdevitt 董事 2007年2月15日 A 17400 0 0 $0
VISIUM BALANCED MASTER FUND, LTD. 10% 所有者 2016年5月31日 S 0 0 0 $0
Constance J. Hallquist · 2023年10月6日 S 2152 0 0 $0
Shirley Macdonald · 2010年5月12日 S 0 0 0 $0
Mary T Travis · 2009年12月17日 S 12583 0 0 $0
Richard J Law · 2009年8月13日 S 62081 0 0 $0
RNI-NV Limited Partnership · 2005年8月8日 S 1088830 0 0 $0
Scott Zion · 2004年7月28日 P 185000 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

ETF持仓 由 18 只交易所交易基金持有

20

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
VRIG · Invesco Actively Managed Exchange... 0.27% 5000000 2026年10月2日 每日
IWC · iShares Trust 0.03% 36261 SH 2026年9月11日 每日
VSS · VANGUARD INTERNATIONAL EQUITY IND... 0.01% 16856 SH 2026年8月19日 每日
DFSV · Dimensional ETF Trust 0.01% 60623 NS 2026年7月31日 N-PORT
DXUV · Dimensional ETF Trust 0.00% 2012 NS 2026年7月31日 N-PORT
DFAS · Dimensional ETF Trust 0.00% 37570 NS 2026年7月31日 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.00% 5322 SH 2026年10月2日 每日
DCOR · Dimensional ETF Trust 0.00% 2019 NS 2026年7月31日 N-PORT
DFUS · Dimensional ETF Trust 0.00% 2079 NS 2026年7月31日 N-PORT
DFAC · Dimensional ETF Trust 0.00% 5600 NS 2026年7月31日 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 115543 SH 2026年8月19日 每日
VTI · VANGUARD INDEX FUNDS 0.00% 318980 SH 2026年8月19日 每日
VXUS · VANGUARD STAR FUNDS 0.00% 64351 SH 2026年8月19日 每日
VGK · VANGUARD INTERNATIONAL EQUITY IND... 0.00% 9806 SH 2026年8月19日 每日
VT · VANGUARD INTERNATIONAL EQUITY IND... 0.00% 3076 SH 2026年8月19日 每日
VEA · VANGUARD TAX-MANAGED FUNDS 0.00% 42929 SH 2026年8月19日 每日
VSGX · VANGUARD WORLD FUND 0.00% 1003 SH 2026年8月19日 每日
SMLF · iShares Trust · 123005 SH 2026年9月11日 每日

MED 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

21
评级 · 9 位分析师 卖出
中位数目标 $12.00 +2.3%
0 0.0% 强烈买入
0 0.0% 买入
4 44.4% 持有
4 44.4% 卖出
1 11.1% 强烈卖出

12个月价格目标

1 位分析师 · 2026-09-27

平均目标 $12.00 +2.3%

最低$12.00 平均值$12.00 最高$12.00

同行比较(GICS 子行业) 关键指标与行业同行对比

22

财年依据,价格截至各公司上一个财年末收盘价。

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
UPXI $62M -0.2 58.1% -984.3% 9654.9% 89.5%
FTLF · 25.8 26.4% · · ·
SKIN $177M -8.7 -10.0% -3.2% -14.1% 65.3%
LFVN $78M 15.6 -20.1% 2.8% 15.2% 77.6%

我的指标 您的个人关注列表 — 来自完整基本面的选定行

26

选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。

您的选择已保存,并会跟随您浏览所有股票。

来源:SEC 10-Q 于 八月 3, 2026 申报